Correlations between in vitro potency of polyethylene glycol-protein conjugates and their chromatographic behavior

被引:16
作者
Caserman, Simon [2 ]
Kusterle, Mateja [1 ]
Kunstelj, Menci [1 ]
Milunovic, Tanja [2 ]
Schiefermeier, Mark [3 ]
Jevsevar, Simona [1 ]
Porekar, Vladka Gaberc [2 ]
机构
[1] Lek Pharmaceut, SI-1526 Ljubljana, Slovenia
[2] Natl Inst Chem, SI-1000 Ljubljana, Slovenia
[3] Sandoz, BPO Analyt, A-6250 Kundl, Austria
关键词
PEG; Pegylation; Interferon alpha-2b; Dynamic light scattering; Size exclusion chromatography; Cation exchange chromatography; In vitro potency; Reporter gene assay; LINEAR POLY(ETHYLENE GLYCOL); INTERFERON ALPHA-2A; PEGYLATION; SIZE; SITE;
D O I
10.1016/j.ab.2009.03.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Pegylation is the most Widely Used and accepted methodology for half-life extension Of biopharmaceutical drugs that also improves physicochemical and biological characteristics of proteins considerably. Most of the positive pharmacological effects of pegylated proteins are believed to be related to an increased hydrodynamic volume and Molecular size. To explore the size impact of polyethylene glycol (PEG) on in vitro potency, a series of well-defined conjugates of interferon alpha-2b (IFN) were prepared with PEGs of different lengths and shapes specifically attached to the N-terminal amino group Of the protein. Specificity of the attachment was confirmed by peptide mapping and mass spectroscopy. When potency Values determined by reporter gene assay were correlated with methods For molecular weight and size characterization, such as size exclusion chromatography and dynamic light scattering, rough parallels were found. Unexpectedly, the retention times oil cation exchange chromatography showed much higher correlation with experimentally determined in vitro potency. It appears that in a series of N-terminally pegylated IFNs, their in vitro potency could be predicted from the retention times oil the cation exchange chromatography columns, probably because both methods reflect not only the influence of molecular size but also the impact of protein masking exerted by attached PEG moiety. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 19 条
[1]   Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C [J].
Bailon, P ;
Palleroni, A ;
Schaffer, CA ;
Spence, CL ;
Fung, WJ ;
Porter, JE ;
Ehrlich, GK ;
Pan, W ;
Xu, ZX ;
Modi, MW ;
Farid, A ;
Berthold, W .
BIOCONJUGATE CHEMISTRY, 2001, 12 (02) :195-202
[2]   Thermal stability of the WHO international standard of interferon alpha 2b (IFN-α2b):: Application of new reporter gene assay for IFN-α2b potency determinations [J].
Caserman, Simon ;
Menart, Viktor ;
Das, Rose Gaines ;
Williams, Stella ;
Meager, Anthony .
JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 319 (1-2) :6-12
[3]   Role of ion ligands in the attachment of poly(ethylene oxide) to a charged surface [J].
Chai, L ;
Klein, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (04) :1104-1105
[4]   Prediction of the viscosity radius and the size exclusion chromatography behavior of PEGylated proteins [J].
Fee, CJ ;
Van Alstine, JM .
BIOCONJUGATE CHEMISTRY, 2004, 15 (06) :1304-1313
[5]   Size comparison between proteins PEGylated with branched and linear Poly(Ethylene glycol) molecules [J].
Fee, Conan J. .
BIOTECHNOLOGY AND BIOENGINEERING, 2007, 98 (04) :725-731
[6]   Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon α-2a (PEGASYS) [J].
Foser, S ;
Schacher, A ;
Weyer, KA ;
Brugger, D ;
Dietel, E ;
Marti, S ;
Schreitmüller, T .
PROTEIN EXPRESSION AND PURIFICATION, 2003, 30 (01) :78-87
[7]  
Gaberc-Porekar V, 2008, CURR OPIN DRUG DISC, V11, P242
[8]   Site of pegylation and polyethylene glycol molecule size attenuate interferon-α antiviral and antiproliferative activities through the JAK/STAT signaling pathway [J].
Grace, MJ ;
Lee, S ;
Bradshaw, S ;
Chapman, J ;
Spond, J ;
Cox, S ;
DeLorenzo, M ;
Brassard, D ;
Wylie, D ;
Cannon-Carlson, S ;
Cullen, C ;
Indelicato, S ;
Voloch, M ;
Bordens, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (08) :6327-6336
[9]   Pegylation - A novel process for modifying pharmacokinetics [J].
Harris, JM ;
Martin, NE ;
Modi, M .
CLINICAL PHARMACOKINETICS, 2001, 40 (07) :539-551
[10]   Mono-N-terminal poly(ethylene glycol)-protein conjugates [J].
Kinstler, O ;
Molineux, G ;
Treuheit, M ;
Ladd, D ;
Gegg, C .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (04) :477-485